blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1150746

EP1150746 - THE USE OF 4-H-1-BENZOPRYAN-4-ONE DERIVATIVES AS INHIBITORS OF SMOOTH MUSCLE CELL PROLIFERATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.07.2005
Database last updated on 17.07.2024
Most recent event   Tooltip17.06.2016Change - lapse in a contracting statepublished on 20.07.2016  [2016/29]
Applicant(s)For all designated states
Aventis Pharmaceuticals Inc.
Route 202-206, P.O. Box 6800
Bridgewater, NJ 08807-0800 / US
For all designated states
THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
201 West 7th Street
Austin, Texas 78701 / US
[N/P]
Former [2004/37]For all designated states
Aventis Pharmaceuticals Inc.
Route 202-206, P.O. Box 6800
Bridgewater, NJ 08807-0800 / US
For all designated states
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
201 West 7th Street
Austin, Texas 78701 / US
Former [2001/45]For all designated states
Aventis Pharmaceuticals Inc.
Route 202-206, P.O. Box 6800
Bridgewater, NJ 08807-0800 / US
For all designated states
BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM
201 West 7th Street
Austin, Texas 78701 / US
Inventor(s)01 / PATTERSON, Winston, Campbell
1915 Avenue M
Galveston, TX 77550 / US
02 / DUMONT, Jennifer, A.
37 Fawn Terrace Lane
Groton, MA 01450 / US
 [2001/45]
Representative(s)Wein, Elmar Michael
Sanofi-Aventis Deutschland GmbH
Global Intellectual Property Department
Industriepark Höchst
Gebäude K 703
65926 Frankfurt am Main / DE
[N/P]
Former [2001/45]Wein, Elmar Michael, Dr.
Aventis Pharma Deutschland GmbH, Patent- und Lizenzabteilung, K 801, Industriepark Höchst
65926 Frankfurt am Main / DE
Application number, filing date00909918.518.01.2000
[2001/45]
WO2000US01104
Priority number, dateUS1999024338001.02.1999         Original published format: US 243380
US1999046866521.12.1999         Original published format: US 468665
[2001/45]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0044362
Date:03.08.2000
Language:EN
[2000/31]
Type: A2 Application without search report 
No.:EP1150746
Date:07.11.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 03.08.2000 takes the place of the publication of the European patent application.
[2001/45]
Type: B1 Patent specification 
No.:EP1150746
Date:08.09.2004
Language:EN
[2004/37]
Search report(s)International search report - published on:EP05.04.2001
ClassificationIPC:A61P9/10, A61P9/00, A61K31/445
[2001/45]
CPC:
A61K31/453 (EP,US); A61K31/436 (KR); A61P21/00 (EP);
A61P35/00 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61P9/10 (EP); A61P9/14 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2004/37]
Former [2001/45]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
Extension statesAL05.10.2001
LT05.10.2001
LV05.10.2001
MK05.10.2001
RO05.10.2001
SI05.10.2001
TitleGerman:VERWENDUNG VON 4-H-1-BENZOPYRAN-4-ON-DERIVATEN ALS INHIBITOREN DER PROLIFERATION VON GLATTEN MUSKELZELLEN[2004/10]
English:THE USE OF 4-H-1-BENZOPRYAN-4-ONE DERIVATIVES AS INHIBITORS OF SMOOTH MUSCLE CELL PROLIFERATION[2001/45]
French:UTILISATION DE DERIVES DU 4-H-1-BENZOPYRAN-4-ONE COMME INHIBITEURS DE LA PROLIFERATION DES CELLULES DE MUSCLES LISSES[2001/45]
Former [2001/45]VERWENDUNG VON 4-H-1-BENZOPYRAN-4-ON-DERIVATE ALS INHIBITOREN DER PROLIFERATION VON GLATTEN MUSKELZELLEN
Entry into regional phase03.09.2001National basic fee paid 
05.10.2001Designation fee(s) paid 
05.10.2001Examination fee paid 
Examination procedure14.08.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
05.10.2001Examination requested  [2001/48]
09.09.2002Despatch of a communication from the examining division (Time limit: M04)
25.02.2003Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
05.05.2003Reply to a communication from the examining division
30.01.2004Communication of intention to grant the patent
09.06.2004Fee for grant paid
09.06.2004Fee for publishing/printing paid
Opposition(s)09.06.2005No opposition filed within time limit [2005/35]
Request for further processing for:05.05.2003Request for further processing filed
06.05.2003Full payment received (date of receipt of payment)
Request granted
21.05.2003Decision despatched
Fees paidRenewal fee
31.01.2002Renewal fee patent year 03
20.01.2003Renewal fee patent year 04
02.02.2004Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipMC31.01.2005
[2016/29]
Former [2010/20]MC31.01.2005
Former [2007/34]IT18.01.2005
MC31.01.2005
Former [2006/14]MC31.01.2005
Cited inInternational search[X]WO9716447  (MITOTIX INC [US], et al) [X] 1,5,6,9 * page 9, lines 1-8; claims 1-8,10,14-18,20,21,23-25,27,28,30 * * page 15, lines 34-37 * * page 28, lines 24-29 *;
 [A]WO9742949  (BRISTOL MYERS SQUIBB CO [US]) [A] 1-3,5-9 * page 8, lines 23-27; claims 1-3; tables 1,2 *;
 [XA]WO9813344  (BRISTOL MYERS SQUIBB CO [US]) [X] 1-3,5-7,9 * page 5, lines 25-30; claim 22 * [A] 8;
 [A]WO9833798  (WARNER LAMBERT CO [US], et al) [A] 1-9 * page 1, lines 19-23; claims 25,35 ** page 3, lines 9-17 *;
 [PX]  - RUEF, JOHANNES ET AL, "Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation in vivo after carotid injury in the rat", CIRCULATION (1999), 100(6), 659-665, XP000957367 [PX] 1-5,9 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.